The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and … – Nature.com
|
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and …
Nature.com Allogeneic hematopoietic stem cell transplantation remains a major therapeutic approach for hematological malignancies. Its success is limited by acute graft versus host disease (GvHD), a life-threatening complication which is a complex process … |
